Atlas Trials

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

Clinical trial NCT01827865 · COMPLETED

Trial details

NCT number
NCT01827865
Sponsor
IPCA Laboratories Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting
Start date
2012-11-01
Primary completion
2012-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.